3/2
07:35 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/2
07:00 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences
1/23
05:07 pm
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
Neutral
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
1/9
07:41 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
1/9
07:00 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
1/5
07:00 am
mplt
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Low
Report
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
12/20
01:30 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
12/16
07:00 am
mplt
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Medium
Report
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies